EARNINGS: GENinCode loss narrows; Billington sales and profit jump
29th Sep 2026 15:30
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 0.625p on 12-10-2026 at 18:35:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.65p |
| Sell | 0.60p |
| Last Trade: | Buy 117.00 at 0.638p |
| Day's Volume: | 1,007,932 |
| Last Close: | 0.625p |
| Open: | 0.625p |
| ISIN: | GB00BL97B504 |
| Day's Range | 0.625p - 0.625p |
| 52wk Range: | 0.588p - 4.25p |
| Market Capitalisation: | £4.71m |
| VWAP: | 0.636456p |
| Shares in Issue: | 753.04m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Genincode (GENI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 117 | 0.638p | Ordinary |
16:18:14 - 12-Oct-26 |
| Buy* | 15 | 0.638p | Ordinary |
16:15:08 - 12-Oct-26 |
| Buy* | 17 | 0.638p | Ordinary |
16:14:23 - 12-Oct-26 |
| Buy* | 21 | 0.638p | Ordinary |
16:13:26 - 12-Oct-26 |
| Sell* | 50,000 | 0.6022p | Ordinary |
15:02:38 - 12-Oct-26 |
| Buy* | 3,136 | 0.638p | Ordinary |
13:52:04 - 12-Oct-26 |
| Buy* | 4,396 | 0.638p | Ordinary |
11:12:53 - 12-Oct-26 |
| Buy* | 643 | 0.65p | SI Trade |
10:45:59 - 12-Oct-26 |
| Buy* | 2,412 | 0.65p | SI Trade |
10:23:01 - 12-Oct-26 |
| Sell* | 521 | 0.60p | SI Trade |
10:23:01 - 12-Oct-26 |
Genincode (GENI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Sep 2026 4:11 pm | RNS | Holding(s) in Company |
| 29th Sep 2026 7:00 am | RNS | Half-year Financial Report |
| 22nd Sep 2026 7:00 am | RNS | Notice of Results |
| 28th Aug 2026 7:00 am | RNS | CARDIO inCode-Score milestone clinical results |
| 1st Jul 2026 1:30 pm | RNS | Result of AGM |
| 11th Jun 2026 5:42 pm | RNS | Holding(s) in Company |
| 10th Jun 2026 4:53 pm | RNS | Holding(s) in Company |
| 8th Jun 2026 7:00 am | RNS | Final Results |
| 4th Jun 2026 6:02 pm | RNS | Holding(s) in Company |
| 3rd Jun 2026 11:03 am | RNS | Holding(s) in Company |